- Preparing For Appointments
- Contact Us
- Maps and Directions
- Clinical Trials
- Our Physicians
- Frequently Asked Questions
Events & Groups:
Join Us On Facebook.
Follow us on Twitter.
Press Releases
Research Collaborations to Benefit Cancer Patients
May 15, 2009
HudsonAlpha researchers are currently expanding the world wide effort to map the cancer genome by collaborating with Clearview Cancer Institute, Huntsville Hospital, and Huntsville physicians to receive cancer samples for testing purposes. HudsonAlpha is one of seven Cancer Genome Characterization Centers in the United States that currently study the differences between normal cells and the malignant cells of glioblastoma (brain), lung or ovarian cancer.
HudsonAlpha President and Director Dr. Richard Myers (formerly, Chair of genetics, Stanford University) and Dr. Devin Absher, formerly from Stanford, won a National Institute of Health (NIH) grant to establish a Cancer Genome Characterization Center (CFCC) for The Cancer Genome Atlas pilot project.
By studying samples from cancer tumors, scientists will search for mutations in cancer cells. These mutations can be studied further for development of therapeutic interventions.
“We are going to witness a watershed of advances in treatment within the next several years. It’s an exciting time to be involved in cancer research collaborations with HudsonAlpha Institute. Patients will benefit from the discovery of novel treatments and targeted, personalized medicine,” according to Dr. Marshall Schreeder, one of the study’s principal investigators.